Successful oral treatment of Ganciclovir resistant cytomegalovirus with Maribavir in the context of primary immunodeficiency: First case report and review

- This case involves a primary immunodeficient patient with cytomegalovirus (CMV).
- The patient developed genetic Ganciclovir resistance in the CMV.
- The patient had a good response to Maribavir.
- Treatments such as Foscarnet, Cidofovir, Leflunomide and others may also be used.